Arax Advisory Partners’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2K Sell
1,855
-20,301
-92% -$139K ﹤0.01% 2265
2025
Q4
$43.9K Buy
22,156
+5,925
+37% +$13.4K ﹤0.01% 1676
2025
Q3
$39.9K Buy
16,231
+15,631
+2,605% +$40.3K ﹤0.01% 1936
2025
Q2
$1.58K Hold
600
﹤0.01% 2643
2025
Q1
$1.81K Hold
600
﹤0.01% 2100
2024
Q4
$1.54K Sell
600
-8
-1% -$33 ﹤0.01% 2070
2024
Q3
$2.26K Sell
608
-236
-28% -$1.09K ﹤0.01% 2025
2024
Q2
$5.33K Buy
844
+244
+41% +$1.61K ﹤0.01% 1569
2024
Q1
$3.22K Hold
600
﹤0.01% 974
2023
Q4
$3.01K Hold
600
﹤0.01% 967
2023
Q3
$1.01K Hold
600
﹤0.01% 1122
2023
Q2
$1.67K Hold
600
﹤0.01% 1030
2023
Q1
$1.09K Hold
600
﹤0.01% 1088
2022
Q4
$3.04K Hold
600
﹤0.01% 895
2022
Q3
$3K Hold
600
﹤0.01% 907
2022
Q2
$2K Hold
600
﹤0.01% 949
2022
Q1
$3K Hold
600
﹤0.01% 883
2021
Q4
$4K Hold
600
﹤0.01% 804
2021
Q3
$6K Buy
+600
New +$6.6K ﹤0.01% 732

Other funds holding IBRX